From new trial data to cost comparisons with surgery, a wave of new findings is adding to the framework of how GLP-1s are being used and tested.  Here are five recent GLP-1 developments: 

The FDA has made public dozens of warning letters sent to drug companies accused of misleading or deceptive advertising.  The disclosures come after the agency said Sept. 9 it would be sending thousands of warning letters and 100 cease-and-desist letters…

At its annual meeting and expo in Denver, the National Association of Specialty Pharmacy presented eight awards to healthcare organizations and employees on Sept. 15 in honor of their contributions to the specialty pharmacy industry.  Here are the recipients: Distinguished…

In recent weeks, several health systems and hospitals have opened new or expanded pharmacies.  Editor’s note: This list is not exhaustive. 1. OhioHealth Van Wert Hospital completed its $3.15 million pharmacy expansion project Sept. 17, doubling the facility’s size. 2.…

Childhood vaccination rates in the U.S. have decreased to their lowest levels in years, coming amid turmoil at the CDC and shifting federal guidance on COVID-19 vaccines.  Here are four things to know: 

Eli Lilly said its experimental oral GLP-1 drug orforglipron outperformed Novo Nordisk’s oral semaglutide in a head-to-head phase 3 trial.  In a 52-week study involving 1,698 adults with Type 2 diabetes, the highest dose of orforglipron lowered average blood sugar…

OhioHealth Van Wert Hospital has finished its $3.15 million pharmacy expansion, doubling the facility’s size.  The pharmacy supplies medications for patients across the hospital’s emergency department, surgery, acute care and outpatient infusion services and now has two specialized clean rooms,…

Pharmacy benefit manager Optum Rx has raised reimbursement minimums for brand-name drugs at around 2,300 independent pharmacies nationwide.  The change applies to pharmacies that are not affiliated with a pharmacy services administrative organization, chain or other network, according to a…

Pharmacists at St. Jude Children’s Research Hospital in Memphis, Tenn., have started using 3D-printing technology to help produce compounded medications starting with hydrocortisone formulations.  The hospital is working to integrate the printers within existing U.S. Pharmacopoeia standards for nonsterile and…

Eli Lilly is building a $5 billion manufacturing facility in Richmond, Va. It is the company’s first fully integrated facility for active pharmaceutical ingredients.  The site is also intended to support the drugmaker’s bioconjugate platform and monoclonal antibody portfolio, including…